TREM1 and neoplasm: While TREM1 expression positively correlates with markers of alternatively activated macrophages and MDSCs, as well as known cytokine targets downstream of TREM-1 activation, TREM1 negatively correlates with markers of anti-tumor immunity and exhibits associations with inferior clinical outcomes in tumors with otherwise advantageous immune characteristics.